Swedish 3D bioprinting firm CELLINK and the Academic Center for Dentistry Amsterdam (ACTA) have been awarded the equivalent of over $1 million USD (SEK 10 million) for a materials development project. Scheduled to run for three years, the funding was awarded by the European Union, with 50% of costs to be delivered by Horizon 2020 […]
21 Replies to “CELLINK awarded $1M in EU funding to develop 3D bioprinter ink”
Comments are closed.